droxidopa
droxidopa is listed in the FDA National Drug Code directory with 15 NDC codes, marketed under brand names including droxidopa, Droxidopa, Northera. Available dosage form: capsule.
Drug Details
- Generic Name
- droxidopa
- Brand Names
- droxidopa, Droxidopa, Northera
- Application Number
- ANDA215265
- Sponsor
- Slate Run Pharmaceuticals, LLC
- NDC Codes
- 15
- Dosage Forms
- CAPSULE
- Routes
- ORAL
- Active Ingredients
- DROXIDOPA
Indications and Usage
1 INDICATIONS AND USAGE Droxidopa capsule is indicated for the treatment of orthostatic dizziness, lightheadedness, or the “feeling that you are about to black out” in adult patients with symptomatic neurogenic orthostatic hypotension (nOH) caused by primary autonomic failure (Parkinson's disease [PD], multiple system atrophy, and pure autonomic failure), dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy. Effectiveness beyond 2 weeks of treatment has not been established. The continued effectiveness of Droxidopa capsule should be assessed periodically. Droxidopa capsule is indicated for the treatment of orthostatic dizziness, lightheadedness, or the “feeling that you are about to black out” in adult patients with symptomatic neurogenic orthostatic hypotension (nOH) caused by primary autonomic failure (Parkinson's disease [PD], multiple system atrophy, and pure autonomic failure), dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy. Effectiveness beyond 2 weeks of treatment has not been established. The continued effectiveness of Droxidoa capsule should be assessed periodically ( 1 ).